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摘要 
干擾素a (Interferon alpha IFN a)屬於第一類干擾素并有很多的亞型.它們都 
耐酸.有些亞型已被確認其特徵：誘發抗病毒狀態(anti-viral state),上調主组织 
相容性复合抗原-I (Major Histocompatibility Complex-I M H C - I )以及 Mx 蛋白質 
( M x protein),而且對癌細胞有抗增生(anti-proUferative)的作用. 
在小鼠{Mus Musculus)中，干擾素0C家族有起碼14個基因以及3個假基 
因.最近在小鼠基因組的測序過程中被新發現的有小鼠干擾素a (MuIFN a ) 亞 
型 1 2， 1 3及 1 4 . MuIFN all已被發現在小鼠胎纖維母細胞（murine embryo 
fibroblast)被表逹.它的抗病毒以及抗增生功能也剛剛被確定.但它其他的生物 
性質以及基因的調控則未有詳細的硏究lem 
在這報告中，我們硏究了 MuEFN al2的其他生物性質以及基因的調控.我 
們用C0S-1細胞腺製造了重組MuIFN a l 2 ( r M u I F N a l 2 ) .我們用M T T法（M T T 
cell proliferation a s s ay )去硏究 rMuIFN al2對小鼠骨髓性白血病癌細胞腺JCS 
增生的影響.除此之外，我們還用碘化丙淀(Propidium iodide PI)以及流式細胞 
儀去硏究rMuIFN al2對JCS的細胞週期的影響.JCS以及初級巨•細胞 
(primary macrophage)的MHC-I的上調也被硏究.爲了硏究MuIFN a l 2的抗病 
毒能力，我們直接把MuIFN an基因轉染到L929細胞腺內，並隨之用流感病 
毒測試（vims challenge).結果明確的顯示了 MuIFN all有強力的抗病毒功效. 
MUIFN al2在L929細胞腺中對病毒以及雙鏈核糖核酸（polyLpolyC)誘發的 
反應，以及在不同的Balb/c小鼠組織中的表達也用RT-PCR方法（Reverse 
transcription-polymerase chain reaction)作了研究. 
重組MuIFN al2的抗增生能力可在MTT法中示範到.細胞週期的硏究顯 
示這個抗增生能力是因爲細胞的调亡（apoptosis). rMuIFN al2可上調JCS或巨 








Interferon alpha (IFN a) belongs to type I interferons and has many different 
subtypes. They are acid-stable. Some members were confirmed with characteristic 
ability of inducing anti-viral state, up regulation of Major Histocompatibility 
Conq)lex I (MHC-I) antigen and Mx protein of cells, and have anti-proliferation 
activity upon cancer cells. 
In mouse, Mus Musculus, the IFN a family consists of at least 14 genes and 3 
pseudogenes. The most recent ones discovered through DNA sequencing of the 
mouse genome are murine interferon alpha (MuIFN a) subtype 12, 13 and 14. 
MuIFN a subtype 12 was found to be expressed in murine embryo fibroblast. Its 
anti-viral and anti-proliferation activities were just recently reported. However, the 
other biological properties of MuIFN all and its gene regulation are not yet studied 
in detail. 
In this report, we studied some other biological activities and the gene regulation 
of MuIFN a 12. We have produced recombinant MuIFN a l2 (rMuIFN a 12) using 
COS-1 cells. We used the MTT cell proliferation assay to study the ability of 
rMuIFN a l2 to inhibit the proliferation of murine myeloid leukemia cell line JCS. In 
addition, we used propidium iodide staining method and flow cytometry to analysis 
the effect of MuIFN a l2 on the cell cycle distribution of the JCS cells. The 
up-regulation of MHC-I in the JCS cells or primary macrophages was also studied 
using flow cytometry. To study the ability of MuIFN a l2 to induce anti-viral state, 
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we directly transfected L929 cells with MuIFN a l2 transgene and challenged the 
cells with Influenza A vims. The result demonstrated that MuIFN a l2 has a strong 
anti-viral effect. MuIFN al2's gene regulation in L929 cells in response to Influenza 
A vims infection or polyI:polyC induction, as well as its expression in various mouse 
tissues of balb/c mice were also studied in detail using reverse 
transcription-polymerase chain reaction (RT-PCR). 
The anti-proliferation activity of rMuIFN a l2 on JCS cell line was demonstrated 
by the MTT cell proliferation assay. The cell cycle distribution analysis showed that 
the anti-proliferation effect was due to apoptosis. rMuIFN a l2 was able to up regulate 
MHC-I on JCS cell line or primary macrophages. We have also demonstrated that 
MuIFN a l2 transgene can induce an anti-viral state in L929 cells against Influenza A 
vims infection. MuIFN a l2 expression was not detected in untreated, virus infected 
or polyI:polyC induced L929 cells. Also, no expression was detected in bone marrow, 
brain, heart, kidney, liver, lung, spleen or thymus of untreated mice. 
Our results here described the unreported properties of MuIFN a 12. The study of 
individual MuIFN a subtypes and the systematic integration of the information will 
finally help to suggest the importance why there are so many different subtypes of 
MuIFN a. 
iv 
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Chapter 1 Introduction 
1.1 The interferon 
Interferon (IFN) was first reported by Isaacs and Lindenmann in 1957. 
Heat-inactivated Influenza virus, added to fragments of chicken chorioallanotic 
membranes, induced the formation of a substance, interferon, which, when added to 
fresh membranes, inhibited the growth of live Influenza vims (Isaacs and Lindenmann, 
1957). 
Interferon is a cytokine. Cytokines are defined as any soluble secreted regulatory 
proteins produced by both lymphoid and non-lymphoid cells that control the growth, 
survival, differentiation and effecting function of tissue cells. They are proteins or 
glycoproteins. Most of the cytokines act on cells in the immediate vicinity of the 
secreting cells. Thus they act in an autocrine or paracrine manner (Meager, 1998; 
Nicola, 1994). Fig. 1.1 shows the 3D structure of recombinant human inteferon alpha 
(HuIFN a) subtype 2B determined by X ray crystallocraphy (Radhakrishnan et al., 
1996). 
1.1.1 About type I IFN 
Interferons are classified into two distinct types, the type I and the type II 
interferon. Type I IFN is in general acid-stable (at pH 2) while type II IFN is pH 
sensitive. Type I IFN consists of interferon a, p, © (Adolf et al., 1990), i (Sen and 
Ransohoff, 1997), limitin (Oritani et al, 2000), K (LaFleur et al” 2001), e and 
5 (Vassileva et al., 2003). IFN co are found in most mammalian species excluding 
mouse (Flores et al., 1991). IFN x is essential for establishment of pregnancy in cattle 
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and sheep (Cross and Roberts, 1991). Type II IFN is structurally and molecularly 
unrelated to the type I IFN (Farrar and Schreiber, 1993). 
In general, type I IFN is produced by cells after stimulating with inducer or by 
vims infection. Type I IFNs are produced by almost all cell types and their actions are 
less cell-type or tissue specific. The proteins of type I IFN are similar in size. In 
mouse, the interferon alpha (MuIFN a) is a femily of at least 14 subtypes (van Pesch 
et al” 2004). The proteins consist of 165 or 166 amino acids, except for MuIFN a4 
which has only 161 amino acids (a short inframe deletion of 5 amino acids) (Kelley 
and Pitha, 1985; van Pesch et al., 2004). IFN a proteins consist of four conserved 
cysteines which form two intramolecular disulfide bonds. All proteins of IFN a 
subtypes share about 60% or more homology in amino acid sequence. In general, 
while human interferon beta (HuDFN P) is glycosylated, most of the HuIFN a were 
not N-glycosylated. However in mouse, 10 out of 14 MuIFN a subtypes were 
N-glycosylated and none was 0-glycosylated (van Pesch et al.，2004). IFN P has 166 
amino acids while both IFN © and IFN x have 172 amino acids. IFN P and IFN a 
have about 25 to 30% sequence homology. (Sen and Ransohoff, 1993). 
In human and mouse, type I IFN genes are unusual that they are all intronless. 
However, it was found that in Atlantic Salmonic fish and some other organisms the 
type I IFN genes are with intron. (Robertsen et al., 2003). In human, type I IFN genes 
are all closely clustered on the short arm of chromosome 9. Type I IFN in human 
consist of at least 13 different IFN a genes, one IFN P and six IFN o, in which five of 
them are pseudogenes. HuIFN a and MuIFN a gene share about 70% of DNA 
sequence homology, and 40% in protein sequences. (Sen & Ranshohoff，1997). 
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1.1.2 IFN a/p receptor and signal transduction 
All the type I IFNs (including limitin) bind to the same receptor, the IFNoc/p 
receptor, for which they coiiq)ete with the same receptor in binidng experiments. 
(Flores et al.’ 1991; Oritani et al, 2000). DFNoc/p receptor has two major subunits 
involved in cell signalling, IFNoRl and IFN(xR2c with molecular weight of 110 kDa 
and 95-100 kDa respectively (Domanski et al.’ 1995). 
1.1.3 IFN induction 
The gene regulation of IFN a is more complex and poorly understood, when 
comparing to that of IFN P. MuIFN a promoters contain sites that are related to 
Positive regulatory domain (PRD) I and ATF-2-binding sites. (Macdonald et al, 
1990). The expression pattern of the MuIFN a genes was different for different 
cells-inducer pairs used (Fung et al, 2004). 
The gene regulation of IFN a is complex, which may give rise to the robust, 
auto-amplification features of IFN expression pattern. Fig. 1.2 shows the current 
model of IFN induction. The mechanism involves a constitutively expressed fector 
interferon regulatory factor (IRF) 3 (IRF-3), and a normally weakly expressed and 
labile fector IRF-7. On viral infection, IRF-3 is largely phosphorylated and 
translocated into the nucleus, where it activates IFN P gene transcription, as well as 
other genes that are also induced by IFN oc/p (Nakaya et al” 2001). The viruses also 
activates NF-KB, a transcription fector that act on the IFN |3 promoter (Wathelet et al.， 
1998; Schafer et al, 1998). The weakly but constitutively expressed IRF-7 also 
activates the IFN a and IFN P genes. In turn, the de novo, virus-induced IFN oc/p 
activates back the Jak protein tyrosine kinases (Jakl and Tyk2) and lead to the 
formation of interferon-stimulated gene factor-3 (ISGF-3) and interferon alpha 
3 
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activated factor (AAF) coiiq)lexes. ISGF-3 activates several IFN-inducible genes 
(including IRF-7) (Nakaya et al” 2001) while the AAF mediates activation ofIRF-1. 
The IRF-1 intum induces other genes. Thus the de novo synthesis of IRF-7, which is 
induced by IFN o/p, is crucial for the up-regulation of IFN oc/p production by a 
positive-feedback mechanism (Marie et al” 1998; Sato et al； 1998; Taniguchi and 
Takaoka, 2002). 
1.1.4 Functions: 
(i) Anti-viral activity of IFN a 
Interferons provide a first line of defense before the specific acquired immune 
response takes place. Type I IFN induces the production of various genes. For genes 
that may contribute to the anti-viral activity of type I IFNs, the following genes are 
studied most in detail: Protein Kinase R (PKR), the 2-5A synthetase/RNase L system 
(2-5A system) and the Mx protein femily. These proteins inhibit the virus replication 
at different stages of infection. 
a. PKR 
PKR expresses constitutively in many cells, and the levels are greatly 
increased after the exposure to type I IFN. Its molecular weight is 65 kDa (Feng et al., 
1992). PKR is a major mediator of the antiviral and antiproliferative activities of IFNs 
(Chong et al., 1992; Donze et al； 1995). It is a serine/threonine kinase. PKR has 
shown to control the transcription and translation induced by IFN and is activated by 
dsRNA (Knist et al” 1984; Meurs et al.’ 1990; Feng et al； 1992). 
PKR has two distinct kinase activities: an autophosphorylation reaction and a 
protein kinase activity on exogenous substrates. PKR is present in inactive form that 
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can be activated by dsRNA or other inducers (Hovanessian & GalabrUj 1987). Upon 
activation, the PKR are autophosphorylated on several serine/threonine residues. The 
response of PKR to dsRNA is biphasic. At low concentration of dsRNA, PKR is 
activated, while the activity is inhibited at high concentration. Activated PKR can 
catalyze the phosphorylation of exogenous substrates (Galabru & Hovanessian^ 1985). 
The most studied substrate is the a-subunit of the eukaryotic protein synthesis 
initiation factor eIF2a, in which its phosphorylation blocks the translation initiation 
！ (Leroux & London^ 1982). | 
I 
b. 2-5 A system 
2-5A system is an IFN-regulated RNA degradation system present in cells of 
higher vertebrates. The 2-5A system consists of 2',5'-oligoadenylate synthetases 
(2-5A synthetases) and a ribonuclease, Rnase L. The expression of 2-5A synthetases 
and Rnase L are increased in cells in response to IFN o/p or 丫 but normally they exist 
in inactive form (Zhou et al.，1993). When the system is activated, Rnase L can 
degrade viral or cellular RNA (Carroll et al, 1997; Silverman, 1997). 
The activation of 2-5A system is shown in Fig. 1.3. In the presence of 
cofector dsRNA, 2-5A synthetases polymerizes 2 to 15 ATP molecules into inorganic 
pyrophosphate (PPi) and a series of short oligomers of adenosine with 2' to 5， 
phosphodiester likage, 2’-5’ linked oligoadenylates 2-5A molecules (Zhou et al.’ 
1993). 2-5A then binds to Rnase L and converts it into catalytic active form that 
degrades viral and cellular mRNAs and rRNA, leading to inhibition of protein 
synthesis in virally infected cells (Carroll et al, 1997; Silverman, 1997). 
> ‘ 5 
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c. Mx protein 
The Mx protein femily is able to inhibit the multiplication of several RNA 
viruses, while at first being misunderstood that these proteins only work against 
specific viruses. Originally, Haller et al found that there was mouse strain that have 
endogenous resistance to lethal Influenza virus infection (Haller et al.，1980). Later 
more detailed studies suggested the gene Mx was to be responsible for it. The most 
well-studied proteins are MxA protein in human and the Mxl protein in mouse. 
At first, Mxl protein was shown to have intrinsic antiviral activity and was the 
sole effector of innate immunity against Influenza A virus in mice (Staeheli P., 1986; 
Arnheiter H.，1990). Later, Mx proteins were characterized as high molecular weight 
GTPases, which have significant homology to mammalian dynamins and yeast VPS-1. 
In rodents, there were both nuclear and cytoplasmic Mx proteins, while in most other 
vertebrates, there are only cytoplasmics forms. The antiviral functions of the rodent 
Mx proteins correlate to their subcellular localization. Mxl proteins confer resistance 
to orthomyxoviruses, like Influenza A virus, which was known to replicate in cell 
nucleus. Mxl protein can inhibit the primary transcription of Influenza A vims in 
nucleus as the levels of longest primary trascripts coding for PBl, PB2 and PA were 
reduced in infected cells expressing Mxl protein. Mx2 proteins predominantly inhibit 
viruses that replicate in the cytoplasm. In human, MxA and MxB proteins exist, but 
only MxA has detectable antiviral activity (Haller et al.’ 1998). 
(ii) Anti-proliferation 
DFN a and the IFN a induced proteins were shown to be involved in cell growth 
regulation. The "200-femily" proteins, consists of structurally related murine and 
human proteins was induced by IFN in Daudi Burkitt's lymphoma cells (Wang et al” 
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1999). "Daudi" cells have been the most widely used human cell line that was used to 
study the anti-proliferation effect of IFN a, and was used in quantifying of human 
IFN by anti-proliferation assay. IFN a treatment of Daudi Burkitt's lymphoma cells 
resulted in differential induction of genes like MNDA, IFI-16, and a p202-related 
protein (p202RP). The induction ofp202RP by IFN preceded the growth inhibition by 
IFN (Geng and Choubey, 2000). Their findings support the hypothesis that 
IFN-inducible p202RP and MNDA proteins from the 200-family contribute to the 
growth inhibitory activities of the EFNs. The downstream mechanism could be by 
apoptosis or cell cycle arrest (Sandoval et al, 2004). 
(iii) Immunomodulation 
a. Major Histocompatibility Complex-I (MHC-I) induction 
MHC-I molecules are polymorphic proteins that present portions of cellular 
peptides as antigens on the cell surfece and are critical component to a potential 
cellular immune response (Atta et al., 1995). MHC-I molecules are expressed almost 
ubiquitously in all cells. But tumors or abnormal cells express lower levels of MHC-I 
molecules on their surfaces. Some peptides produced in viral infections or in 
neoplastic transformations could be recognized by proteosome as foreign antigens and 
thus be presented by MHC-I molecules. IFN a mainly positively regulate MHC-I 
molecules, while IFN 丫 can modulate both MHC-I and MHC-II molecules expression 
(Ljunggren et al., 1998). The augmentation of MHC-I expression has been shown to 
effectively regulate and activate cytotoxic T lymphocytes, which are primary effectors 
of cellular immune responses. 
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b. Natural killer cell augmentation 
Another major immunomodulation effect of IFN a is the augmentation of natural 
killer cells. NK cells are non-B non-T lymphocytes with morphology of large granular 
lymphocytes, and are able to recognize and destroy a wide spectrum of tumour cells 
(Trinchieri 1989; Murphy et al.，1987). They are also able to kill some normal cells, 
especially those that are infected by certain viruses. NK cytotoxicity is enhanced in 
vitro in the presence of cytokines such as interleukin-2 (IL-2) and IFN a (Gately et al” 
1998; Reiter 1993). IFN a could enhance the MHC-I expression on NK cells as well 
as augment the killing activity of the NK cells. Ortaldo et al have reported that 
although some IFN a subtypes have usual anti-viral and anti-proliferation activities, 
some IFN a subtypes could have very low NK cell augmentation activity (Ortaldo et 
al” 1984). 
1.1.5 MuIFN a subtypes 
The mouse type I EFN gene cluster has just been fully characterized. The 
individual IFNs have been localized to a cluster similar in size to human IFN cluster 
on the centromere-proximal region of Mus musculus chromosome 4 (Pestka et al.’ 
1987; LaFleur etal” 2001; Weissmann etal., 1986; Oritani etal” 2000; Oritani etal” 
2001). Most of the genes were cloned and studied before 1991, which include 11 
functional subtypes and 1 pseudogene. The more well-studied fimctional subtypes are 
1 
subtype 1，2, 4, 5，6T, 7/10，8/6, 9, 11, A, B. Recently, subtypes 12, 13 and 14 were 
cloned, together with two pseudogenes (Hardjr'e/'^y., 2004; van Pesch etaL, 2003). All 
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1.1.6 Gene expression 
Among the well-known subtypes, some are inducible by vims infection and/or 
by polyI:polyC while some cannot (Fung et al, 2004). The induction of murine cell 
lines by virus or polyI:polyC usually produce a mixed type I IFN preparation which 
consist of a particular subset of IFN a as well as IFN p. (Bista et al.’ 1988; Nyman et 
aU 1998; Larrea etal., 2001; Fung etal., 2004). MuIFN a l4 can also be up-regulated 
by vims (van Pesch et al., 2003). The regulation of MuIFN a l2 gene expression is 
unknown, but it could be detected in murine embryonic fibroblast (Hardy etal’ 2004). 
MuIFN a l3 is quite different in which it is found to be constitutively expressed in 
uninduced L929 cells, and the level does not respond to vims infection by Mengo 
virus (van Pesch et al, 2003). There are evidences that IFN a are expressed during 
embryo development (Riego et al” 1995), which suggest that they may have some 
specific fimction related to the development. 
1.2 Aim of study: Functions and gene expression 
While we are testing the anti-viral and anti-proliferation activities of MuIFN a 12， 
another group has reported evidences that MuIFN a l2 indeed codes for a functional 
protein (van Pesch etal., 2004). And in this study we would like to further study other 
functions of the MuIFN a 12，including the ability to up-regulate MHC-I expression, 
and also MuIFN al2，s gene expression. 
9 
In the report by van Pesch et al. (van Pesch et al, 2004), they amplified RNA 
samples with a pair of consensus IFN primers, cloned the fragments and studied the 
expression profile of IFN a in different situations by sequencing the clones. However, 
by coiiq)armg with the result from our laboratory (Fung et al., 2004), we found that 
their method could not reflect the truth. Thus we developed a PGR primer which may 
be able to detect expression of MuIFN al2 by Reverse transcription 一 polymerase 
chain reaction (RT-PCR). And we are going to use it to test whether MuIFN al2's 
expression can be up-regulated by Influenza A vims infection or polyI:polyC 
induction in L929 cell line. We will also study whether MuIFN a l 2 is expressed in 
untreated mouse tissues. 
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國 
Fig. 1.1 The 3D structure of recombinant human inteferon alpha (HuIFN a) subtype 
2B determined by X ray crystallocraphy (Radhakrishnan et al.’ 1996). Shown in 
ribbon form, Protein Data Bank access code: 1RH2. 
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Fig. 1.2 shows the current model of IFN induction. The mechanism involves a 
constitutively expressed factor interferon regulatory factor (IRF) 3 (IRF-3), and a 
normally weakly expressed and labile factor IRF-7. On viral infection, IRF-3 is 
largely phosphorylated and translocates into the nucleus, where it activates IFN p 
gene transcription, as well as other genes that are also induced by IFN a/p (Nakaya et 
al., 2001). The viruses also activates NF-KB, a transcription factor that act on the I F N 
(3 promoter (Wathelet et al.’ 1998; Schafer et al.’ 1998). The weakly but constitutively 
expressed IRF-7 also activates the IFN a and IFN p genes. In turn, the de novo, 
virus-induced IFN a/p activates back the Jak protein tyrosine kinases (Jakl and Tyk2) 
and lead to the formation of interferon-stimulated gene factor-3 (ISGF-3) and 
interferon alpha activated factor (AAF) complexes. ISGF-3 activates several 
IFN-inducible genes (including IRF-7) (Nakaya et al., 2001) while the AAF mediates 
activation of IRF-1. The IRF-1 intum induces other genes. Thus the de novo synthesis 
of IRF-7, which is induced by IFN oc/p, is crucial for the upregulation of IFN cx/(3 
12 
production by a positive-feedback mechanism (Marie et al.，1998; Sato et al., 1998). 
(Taniguchi and Takaoka, 2002) 
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Inhibition of vims rqilication and protein synthesis 
Fig. 1.3, In the presence of the cofector dsRNA, 2-5 A synthetases polymerizes 2 to 15 
ATP molecules to inorganic pyrophosphate and a series of short oligomers of 
adenosine with 2' to 5' phosphodiester linkage, 2'-5' linked oligoadenylates (2-5A) 
molecules (Zhou et al,，1993). 2-5A in turn binds to RNase L and converts it from 
inactive to catalytic active form. It can then degrade viral and cellular mRNAs and 
rRNA, leading to inhibition of protein synthesis and viral replication (Carroll et al, 
1997; Silverman, 1997). 
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Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 Cell line, bacterial strain, virus strain and plasmid 
vector 
Cell line 




JCS Maker a/., 1993 
Bacterial strain 
Bacteria strain Preparation method 
Escherichia coli (DH5a) con^etent cell was prepared by the 




pEGFP-Nl Clontech 6085-1 
pBhiescript SKII (-) Strategene AA0005 
pGEM-T vector Promega Al 360 
15 
1 
The maps are shown in Fig. 2.1, 2.2 and 2.3 respectively. 
Virus strain 
Virus ATCC no. 
Influenza AKWS 33 VR-219 
Mouse strain 
Balb/c Provided by Laboratory Animal Services 
Centre, the Chinese University of Hong 
Kong 
Egg strain 
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Fig. 2.1 A graphical map showing the features of the plastnid vector pEGFP-Nl. The 
gene bank access number is CVU55762. “eg电” and "CDSl" in the picture represent 
the location of the Enhanced Green Fluorscent Protein gene and the Kanamycin 
resistant gene. The Mult^le cloning site is just upstream of the “eg电” • Graphic 
produced using the program Vector NTI. 
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Fig. 2.2 A graphical map showing the features of the plasmid vector pGEM-T vector, 
included in the pGEM-T easy vector system, a TA cloning kit. Graphic obtained from 
the manual of the kit. 
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Fig. 2.3 A graphic showing the features of the plasmid vector pBluescriptll (SK-). 
Graphic obtained from the manual of the manufacturer. 
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Agar (Bacteriological grade) Ajax 863 
Ampicillin Sigma A9518 
Cesium chloride - optical grade (ultra-pure) GibcoBRL 15507-015 
Diethylaminoethyl (DEAE) dextran Amersham Pharmacia 
17-0350-01 
Diethyl pyrocarbonate (DEPC) Sigma D5758 
Ethylenediamine-tetraacetic acid (EDTA) Sigma ED2SS 
Glycerol Sigma G5516 
Guanidine thiocyanate Sigma G9277 
Tetrazolium salt Sigma M-2128 
3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT) 
Seakem LE agarose BMA 50004 
(Biowhittaker Molecular Applications) 
Sodium bicarbonate Sigma S5761 
Sodium chloride Sigma S9625 
Tris-acetate EDTA buffer Ameresco 796 
Tryptone Oxoid L42 
Yeast extract Oxoid L21 
2.1.3 Culture Media, Buffer and other solutions 
RPMI 1640 (Powder) GibcoBRL 23400-021 
Dulbecco's phosphate-buffered saline (DPBS) GibcoBRL 21600-010 
Dulbecco's Modified Eagle Medium (DMEM) GibcoBRL 12800-017 
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Eagle's Minimum Essential Medium (EMEM) GibcoBRL 41500-034 
Fetal bovine serum (FCS) GibcoBRL 16000-044 
Trypsin-EDTA GibcoBRL 25200-056 
Antibiotic-antimycotic (PSF) GibcoBRL 15240-062 
PSN antibiotic mixture GibcoBRL 15640-055 
2.1.4 Reagents and nucleic acids 
1 kb plus DNA ladder™ GibcoBRL 10787-026 
ATP Pharmacia 27-1006-01 
M-MLV reverse transcriptase; GibcoBRL 28025-013 
5 X first-strand buffer; dithiothreitol (DTT) 
Pd(T)i2-i8 Pharmacia 27-7858-01 
Platinum® Pfic DNA polymerase GibcoBRL 11708-013 
Advantage 2 Polymerase Mix Clontech 8430-1 
PolylipolyC Pharmacia 27-4729 
RNaseOUT (Recombinant ribonuclease inhibitor) GibcoBRL 10777-019 
Smal, 10 X buffer J Promega R6221 
T4 DNA ligase Promega Ml 804 
ThermoprimePL仍 DNA polymerase Advanced Biotechnologies 
AB-0301 
Ultrapure dNTPs sets (2'-deoxynucleoside Pharmacia 27-2035-03 
5'-triphosphate) 
DMRIE-C Invitrogen 10459-014 
Trizol reagent Invitrogen 15596018 
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2.1.5 Reaction kits 
DRhodamine terminator cycle sequencing kit Perkin Elmer 403044 
QIAEX II gel extraction kit Qiagen 20021 
Wizard® Plus SV minipreps DNA purification system Promega A1460 
pGEM-T easy vector system Promega Al 360 
RNase-free Dnasel (RQl RNase-free DNase) Promega M6101 
2.1.6 Solutions 
5.7 M cesium chloride Dissolve 96.0 g CsCl in 100 ml with 0.01 M EDTA 
(M.W. = 168.37) (pH 8.0). Treated with DEPC and then autoclave. 
50 mg/ml DEAE-dextran Dissolve 100 mg ofDEAE-dextran in 2 ml ddHzO 
and sterilize by autoclave. 
DEPC-treated water DEPC was added to MilliQ water with final 
concentration of 0.1% and was then shake 
vigorously. After treating overnight, the solution was 
autoclaved to degrade the remaining DEPC in water. 
0.5 M EDTA Dissolve 18.61 g EDTA in 100 ml ddHiO. Adjust pH 
(M. W. = 372.24) to 8.0 using NaOH. Treated with DEPC and then 
t autoclave. 
Guanidinium thiocyanate Dissolve 50 g of Guanidinium Thiocyanate in 10 ml 
homogenization buffer; 1 M Tris-HCl (pH 7.5)，and add DEPC-treated water 
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4.0 M Guanidinium to 100 ml. Filter the solution through a Whatman No. 
Thiocyanate, 0.1 M Tris-Cl 1 filter or equivalent. This solution is stable and can 
(pH 7.5), 1 % be store indefinitely at room temperature. Just before 
p-mercaptoehtanol use, add p-mercaptoethanol to a final concentration 
o f l %(0.14M). 
PolyI:polyC Sterilized PBS was added to the vial to the final 
concentration with 2 mg/ml. The mixture was heated 
to 50�C to obtain complete solubilization of 
PolyI:polyC. The solution was cool to room 
teii^)erature slowly to insure proper annealing. 
PolyI:polyC was stored at 4°C until use. 
3 M sodium acetate Dissolve 123.04 g NaOAc in 500 ml DEPC treated 
(M.W. = 82.03) ddHzO. Adjust the pH to 5.2 using glacial acetic acid. 
Treated with DEPC and then autoclave. 
Phosphate buffer saline (PBS) 140 mM NaCl, 2.7 mM KCl, 8 mM NazHPO*，1.4 
mM KH2PO4 
FACS medium DPBS + 2% heat-inactivated FCS and 0.05% NaNa 
FACS fixative 1% formaldehyde in phosphate buffer saline 
PBS+ 140 mM NaCl, 2.7 mM KCl, 8 mM NazHPCU, 1.4 
mM KH2PO4, 0.7 mM CaClj, 0.5 mM MgCh (pH 
7.2) 
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2.1.7 Major equipments 
Bench-top microcentrifuge Eppendorf 5415D 
DNA sequencer PE Applied Biosystems 
ABI Prism 3100 genetic 
analyzer 
Gel documentation system Bio-Rad GS-670 
HorizonTM 20.25 gel electrophoresis apparatus and power Gibco 1069BD 
Supply 
SpeedVac concentrator Savant SCllO 
Thermal cycler MJ research PTC-200 
Ultracentrifiige Beckman XL-80 
Spectrophotometer Eppendorf 6131 000.012 
Fluorescent Assisted Cell Sorter (FACS) Becton Dickinson FACS 
Vantage 
ELISA plate reader Molecular Devices 
Spectra max 250 
2.1.8 Primers used: 
德： 11 No. Code Sequences Purpose 
i i 1 » " - J — ： - — I 
. / It j ‘ 
- • Cloning of MuIFN a l2 5'- CCA AAC AGC CCA GAG 
»： ‘ ；i; 1 MF1012 coding sequence (forward) • GACAAA-3' 
::� and RT-PCR | 
1 j 
' JI 一」I . - 」 | j I I I i| 2 MFlOlSj 5'-ATGACAGTTCTCTCCATT Cloning of MuIFN a l2 
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ITTG CT -3， i coding sequence (reverse) 
i ！ ！ 
I I I |andRT-PCR 
I • 
5 ； 
— - • " ‘ ••••；• - p - _•_• 产 一 U - • . .,. —.-- -- -.，,,| -., 一 • • 一 •• . ^ J Cloning of MuIFN a l coding； 
j 丨 5’- ACA CTC ACC ATG OCT AGO 
3 i MF964 丨 sequence (forward) and 
I I CTC-3， I RT-PCR 
I 'I ‘ . -
i Cloning of MuIFN a l coding i 5'- TAC CAT TTG GCT CAG GAC i 
4 MF489 i i sequence (reverse) and ！ TCATTT -3' i 
\ I RT-PCR 
J t I 
— — • •〜丨 ^ >"•-•--'.— ” _ — - . • . - _ • _ : 二 - 二 , 丨 _ 了 _ . . 一 . , . � . , , j — — j I I ~1| ^ 1 i Cloning of MuIFN a4 coding I 5，- CAG AGA GCG ACC AGC j 
5 MF696 丨 i sequence (forward) and 
i ATG TAC-3' 
I RT-PCR 
一 - 丨 r 「 ， 1 — — — • — — — — — — — — - — — — — — — — — “ . 丨 丨 . . 丨 , — . 一 -
！ ~jj I Cloning of MuIFN a4 coding 
I 5'- AAC ACG GTT TTG CAT ATT 
6 MF697 sequence (reverse) and i 
|GAGAAG-3' I ！ I j RT-PCR 
i 
1 — 一 J ^ ‘ - _ � L -一—— I p.- .1 •• — • , J m i| 11 
j 5，- ACC ACA GTC CAT GCC ATC 
{7 MF214 GAPDHprimer (forward) I 
i iAC-3' I ！ 
i i I 5'- TCC ACC ACC CTG TTG CTG 
8 MF215 GAPDH primer (reverse) TA-3， 
RT-PCR detection of MuIFN I 
j 
… … 5 ' - A G A GAA CCT AGA GGG GAA 
9 俯 1107 朋 ttcAGGA_3, al2, designed by Dr. Hardy. | 
(Hardy a/., 2004) | 
RT-PCR detection of MuIFN \ 
… … n 5,-CCT TTG CAG AGA GAC ATG 
10 MFl 108 •广• tt广 ^ ^ • al2, designed by Dr. Hardy. 
ACA TTG CTA-3' ® ^ � 
(Hardy e/fl/., 2004) 25 
2.2 Methods 
2.2.1 Cloning of MuIFN al2, MuIFN a l and MuIFN a4 from L929 
Genomic DNA and their subcloning into pEGFP-Nl mammalian 
expression vector 
2.2.1.1 PCR of MuIFN all 
Genomic DNA from L929 cell line was prepared as described (Sambrook et al, 
2001). MuIFN a l2 was amplified by Advantage 2 polymerase (Clontech) with primer 
pair MF1012/MF1013. The PCR profile used was as follow: 94 4 min, 25 cycles of 
94 1 min, 56 °C 1 min, 72 °C 1 min and then extension at 72 for 3 min. PCR 
products from several reactions may have to be concentrated by standard ethanol 
precipitation. 
2.2.1.2 Gel purification of MuIFN all PCR product 
The concentrated PCR products were separated by electrophoresis in a 1% 
agarose gel with 0.5 |ig/ml ethidimn bromine. After running the gel at 100 V for about 
0.5 h, the gel was exposed to UV source and a band of-600 bp, corresponding to the 
size of MuIFN all coding region, was cut out using a sterile blade. The PCR product 
in the gel was extracted by Qiagen's QIAEXII DNA extraction kit as described in the 
manual. Briefly, the gel was dissolved in QXl buffer, approximately 3 times its 
weight, and 15 nl resins for 12 min at 65 °C and vortexed at 2 min interval. The DNA 
was bound to the resin. The resin was then spun down and washed with 500 |xl of 
QXl buffer. After that the resin was washed twice with the PE buffer and dried in 
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open air. DNA was ehited twice with 15 [i\ of autoclaved MilliQ water. The two 
fractions were poured together and stored in -20�C. The amount of DNA was 
determined by measuring OD260. 
2.2.1.3 Ligation of MuIFN al2 PCR product into pGEM-T vector 
25 ng of MuIFN a l2 PCR product were added to 50 ng ofpGEM-T vector, with 
3 unit of T4 DNA ligase and 5 \x\ of 2x ligation buffer in a 10 reaction (All from 
Promega pGEM-T Easy vector systems). The ligation reaction was kept at 16 °C 
overnight. It was then transformed into DH5a E.coli con^etent cells and spread onto 
LB plates with ampicillin (100 iig/ml, LB A plate). About 16 h later, the clones were 
picked with autoclaved toothpicks and transferred to another LBA plate with squares 
drawn. This master plate was in turn incubated at 37�C overnight. PCR screening 
using the above MuIFN a l2 primer pairs was used to identify clones with the correct 
insert. The PCR profile used was the same as 2.2.1.1. 
2.2.1.4 Sequencing of clones which were positive in PCR screening 
The sequence of the clone was confirmed by DNA sequencing on Applied 
Biosystem ABI 3100 DNA sequencer. Briefly, cycle sequencing using the profile: 96 
°C 3 min, 25 cycles of 96°C 30 s, 50 15 s, 60°C2min and finally 15 overnight 
with 1.6 pmol of primer, was performed as described in the manual. The reaction 
consists of about 250 ng of plasmid, 1.6 pmol primer, 4 \il of reaction mix and 
autoclaved MilliQ water was added up to 10 After the cycle sequencing reaction, 1 
27 
Ill of Sodium acetate (pH 5.2) and 25 pi of 100% reagent grade ethanol was added. 
The sample was kept at -20 °C for 15 min. It was then centrifiiged at 14,000 rpm at 4 
°C for 45 min. The supernatant was carefully removed, and the pellet was washed 
with 200 |il of 70% reagent grade ethanol. The sanq)le was centrifiiged again for 45 
min. The supernatant was removed, and the sample was dried in SpeedVac. The 
sequencing products were then resuspended in 12 |al Hi-Di formamide and loaded into 
the ABI 3100 sequencer. 
2.2.1.5 Subcloning of the gene from pGEM-T vector to pEGFP-Nl. 
After the sequence had been confirmed, the gene MuIFN a l2 was then excised 
from the pGEM-T Easy vector by Xbal and EagI enzyme. The MuIFN a l2 gene 
fragment was then subcloned into pBhiescript II (SK-) vector cut with EagI and Spel. 
Positive clones were screened by PGR as described in 2.2.1.3. The MuIFN a l2 gene 
haboured in pBluescriptll (SK-) vector was then exised by Sad and BamHI enzyme. 
The fragment was subcloned into the Sad and BamHI cut pEGFP-Nl vector. Positive 
clones were screened as described in 2.2.1.3, and named as pEGFP-Nl_MuIFNal2. 
2.2.1.6 Construction of expression vectors for MuIFN a l and MuEFN 
a4 gene. 
MuIFN a l and MuIFN a4 were amplified by Pfic polymerase (Invitrogen) with 
primer pairs (MF964/MF489) and (MF696/MF697) respectively using the same PGR 
profile as above for MuIFN al2. The blunt end PGR products were then ligated into 
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pEGFP-Nl, previously cut with Smal. Gel purification, ligation, transformation, 
screening and DNA sequencing were performed as in 2.2.1.3 and 2.2.1.4. The DNA 
sequences of the inserts confirmed that there were no mutations. The recombinant 
plasmids were designated as pEGFP-Nl_MuIFNal and pEGFP-Nl_MuIFNa4 
respectively. 
2.2.2 Preparation of plasmid DNA 
Plasmid DNA of pEGFP-Nl, pEGFP-Nl_MuIFNal2, pEGFP-Nl_MuIFNal 
and pEGFP-N l_MuIFNa4 were prepared by Promega miniprep kit. Briefly, E.coli 
clones were inoculated in LBK medium and shook in orbital shaker at 37 °C overnight. 
Cells in 10 ml culture were collected by centrifiigation at 6,000 rpm, 4°C for 10 min. 
The cell pellet was resuspended in 250 |al of resuspension solution. 250 pil of lysis 
solution was then added to lyse the cells. Cells were inverted quickly for 4 times to 
mix the solution. 10 |il of alkaline protease was added and the samples were inverted 
4 times. After an incubation period at room ten^erature for about 5 min, 350 \xl of 
neutralization solution was added and the samples were inverted several times to mix 
the content. The samples were then centrifuged at 14,000 rpm at room temperature for 
30 min to remove the debris and/or unwanted materials. After that, the supernatant 
was loaded into promega's mini prep spin column and spun for 1 min. The samples 
were then washed with 750 |il and 250 of washing solution. Finally, the DNA were 
eluted with 100 |il of autoclaved MilliQ water by spinning for 1 min and the filtrate 
were collected in a new microcentrifuge tube. The DNA content were quantified by 
spectroscopy and stored at -20 °C until use. 
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2.2.3 Preparation of Cell culture medium 
Cell culture medium RPMI, EMEM, DMEM were purchased as powder from 
Gibco and prepared as instructed by the manufacturer. Briefly, the powder was 
dissolved in a suitable amount of MilliQ water (95% of final volume). Different 
amount of NaHCOa was added according to instructions by the manufacturer. The 
content was mixed by magnetic stirrer bar. The pH was adjusted to about pH 7.1 or 
7.2. It was 0.2 to 0.3 below the final pH of about 7.4 as filtration will raise the pH by 
0.2 to 0.3. The volume was then adjusted to the final volume. The medium was 
filtered through 0.22 \im Steritop filter by negative pressure inside a class II 
Biological Safety Cabinet. Small aliquot was collected in 15 ml centrifuge tube and 
shook at 37 °C overnight to test for contamination. PSN or PSF antibiotics mixture 
(Gibco) was added to the medium to final 1% before use. The FCS were purchased 
from Gibco and stored as 20 ml aliquots at -20 °C until use. Medium with 10% FCS 
was denoted here as medium name-10 and medium without serum was denoted as 
medium name-0. 
2.2.4 Production of recombinant MuIFN a (rMuIFN a) 
DMRIE-C (Invitrogen) was used for DNA transfection. Transfection was done 
according to manufacturer's manual. Briefly, 2x10^ COS-1 cells/well were seeded in 
6-well plates and incubated at 37 5% CO2 overnight or until 60-80% confluent. 3 
fig of DNA was diluted in 500 |LI1 DMEM-0, while 4 |LI1 ofDMRIE-C was diluted in 
500 |j,l of DMEM-0. The two solutions were then mixed and incubated in room temp 
for 45 min. Cells were then washed with DMEM-0 and overlaid with the 
DNA/DMRIE-C mixture. The cells were fiirther incubated for 7 h before 1 ml of 
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DMEM-20 was added. The culture medium collected 2 d later. Fresh DMEM-10 was 
added and collected again 2 d later. This procedure was repeated 3 times till day 8. 
The supematants collected should contain rMuIFN a which were secreted into the 
supematants. They were filter sterilized using 0.22 [im filter and kept at 4 °C for 
temperately storage. Whenever possible, they were adjusted to pH 2 by IN HCl, 
incubated at 20 °C for 24 h and then neutralized back to pH 7 - 7.5 by IM NaOH. It 
was filter sterilized and stored at 4 °C. 
2.2.5 Production of native MuIFN a by polyI:polyC induction 
The induction of native, mixed type I IFN from L929 by polylipolyC was done 
according to the paper (Trapman et al, 1979). Briefly, L929 cells were grown in 75 
cm^ flask until confluent. It was then washed with 3 ml of DMEM-0. And then 15 ml 
DMEM-0 containing 20 iig/ml polyI:polyC and 400 ng/ml DEAE-dextran was added. 
The cells were incubated at 37�C, 5% CO2 for about 9 h, and was then washed 2-3 
times with DMEM-0. 15 ml DMEM-0 was then re-supplied and the cells were 
re-incubated for 12-16 h or overnight. Supernatant was then collected, serum equal to 
1/9 of the volume were added to adjust the samples into DMEM-10, and were then 
acidified as above. The FCS was added to extend the storage of the MuIFN a. 
if 2.2.6 Influenza A virus strain A/NWS/33 preparation and titration 
Influenza A virus A/NWS/33 was a gift from Dr. NK Mak (HKBU). The vims 
was passed in 10-12 d Leghorn eggs purchased from Jinan Poultry Company, PRC as 
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described in (Fung et al., 2004). Egg shells were drilled carefully. 1x10^ pfii of 
Influenza A virus in 100 PBS+ was injected into each egg by a 25G 1 ml syringe. 
The holes were closed by paraffin wax and the eggs were kept in the 37°C incubator 
for 2-3 d. The eggs were later kept for 4 h at 4°C to kill the embryos. The supernatant 
from the allantoic cavities were collected carefully in a class II Biological Safety 
Cabinet and spun at 1,000 rpm for 10 min. They were then dispensed into screw cap 
tubes, quick freezed and stored in -70°C freezer. The titers of the vims were 
determined by standard MDCK cell plaque assay procedure. 
2.2.7 Vims infection in Influenza A virus challenge assay 
Briefly, the cells were washed two times with PBS+，overlaid with vims 
inoculums of chosen Multiplicity of infection (MOI) and incubated at 37�C，5% CO2 
for 1.5 h (2 ml inoculum for each well in a 6-weU plate). The vims inoculums were 
then removed. Cells were washed two times with PBS+ and DMEM-2 was added. 
The cells were then put back into the incubator. 
2.2.8 Cell culture techniques 
COS-1 cell line was a gift from Dr. Ge Wai (CUHK) and was passed in 
DMEM-10 medium. L929 cell line was obtained from Dr. K. N. Leung (CUHK) and 
passed in either EMEM-10, DMEM-10 or RPMI-10 as denoted. JCS ceU line was also 
obtained from Dr. K. N. Leung and was maintained in RPMI-10. MDCK cell line was 
a gift from Dr. Ooi (CUHK) and was passed in DMEM-10 medium. 
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For suspension cell lines, they were split into new medium according to the ratio 
suggested by ATCC. For adherent cell lines, they were passed before 100% confluent. 
Briefly, at 2 to 3 d intervals, the cells were washed with plenty of autoclaved DPBS 
purchased from Gibco. The DPBS were removed, and different amount of 
Trypsin-EDTA were added to trypsinze the cells. After the detachment of the cells 
from the culture flask, which could be observed by naked eye, 5 ml medium with 
serum were added to neutralize the trypsin. The cells were then diluted with culture 
medium and cultured in new flask with split ratio as suggested by ATCC. 
2.2.9 MTT cell proliferation assay of JCS cell line, for measuring 
MuIFN a anti-proliferation activity 
The assay was performed similarly as described in (Loveland et al., 1992). 
Briefly, 2 fold serial dilution of MuEFN a samples were made in 100 \i\ RPMI-10 
medium using 96 well U-bottom plates. 3x10^ JCS cells in 100 |xl were then added to 
each well. Cell only controls did not contain IFN, while blank controls only contained 
medium. 72 h later, 20 |j,l MTT was added to each well and mixed. The cells were 
further incubated at 37°C, 5% CO2 for 3 h. The cells were then spun at 1,500 rpm for 
10 min and medium were removed as much as possible. 100 jil DMSO was added to 
each well to ehite the dye and the colour intensity was measured by ELISA plate 
reader at 540nm and 690nm. The final reading should be OD540-OD690. Averaged 
...• - X 1 
欲:’ 、•：r. 
blank value was subtracted from all other sanq)le readings. The data were reported as 
% growth inhibition vs amount of IFN in |il, in which the value was calculated as (OD 
.：广 . . . : of sanq)le/OD of averaged cell only control) x 100 %. The results were then analyzed 
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by Prism 4.0 software, a rectangular hyperbola curve was fitted to each set of data. 
OD readings which were out of a previously established linear range were omitted. 
2.2.10 Quantitative analysis of MuIFN a 
To quantify the MuIFN a samples, 1 Laboratory Unit (LU) is defined as the 
amount of MuIFN a that bring about a 50% growth inhibition of the JCS cell line. 
And the value can be directly calculated using the Prism 4.0 software. 
2.2.11 Flow cytofluorometric analysis of cell cycle of MuIFN a 
treated JCS cells by propidium iodide staining 
1x10^ JCS cells were seeded in 10 ml RPMI-10 medium in four 25cm^ flask. 200 
|xl mock supernatant, 200 LU/ml rMuIFN a l2 (diluted from -200^1 rMuIFN all) or 
200 LU/ml rMuIFN a4 (diluted from �200nl rMuIFN a4) were added to three of the 
flasks. One was left untreated throughout the study. 24 h later, the cells were spun 
down at 1,500 rpm for 5 min and washed with cold DPBS. The pellets were then 
resuspended and fixed in 2 ml cold 70% reagent grade ethanol and left overnight at 
4°C. 24 h later, the cells were spun down and washed twice with cold DPBS as before. 
Finally the cells were resuspended in 1.7 ml cold DPBS, with 100 \lI RNaseA solution 
and 200 |il propidium iodide solution. The samples were incubated for 30 min at 37°C 
protected from light. After that the samples were transferred into Fluorescent 
Activated Cell Sorter (FACS) tubes and were analyzed by the Beckman Dickinson 
FACS machine immediately. The DNA content of the cells was measured and the cell 
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numbers were counted. The data were presented by the CellQuest software and cell 
cycle distribution were analyzed by the ModFit software. 
2.2.12 FACS study on the effect of MuIFN a on MHC-I up-regulation 
in JCS cells 
1x10^ JCS cells were incubated in 2 ml RPMI-10, with 5 LU/ml, 50 LU/ml or 
500 LU/ml of different rMuIFN a. 36 h later the cells were collected. They were 
harvested by putting in room ten]5)erature for 30 min. The cell numbers were counted, 
and then 1x10^ cells were spun at 1,500 rpm for 5 min and were resuspended in 200 
FACS medium. Cells were washed once by FACS medium. The pellets were 
resuspended with 10 |ig/ml rat IgG and 10 |ig/ml mouse IgG in DPBS and incubated 
in 4°C for 30 min with occasional shaking. The cells were washed once with FACS 
medium and then resuspended with 0.5 jil FITC-conjugated anti-mouse MHC-I 
antibody in 100 solution which consists of 50 |il DPBS and 50 [i\ FACS medium. 
The sanq)les were incubated at 4�C for 1 h and then washed twice with FACS 
mediunL Finally the pellets were resuspended in 600 |il FACS fixative and the 
analysis was performed in the FACS machine. 
t 
2.2.13 FACS study on the effect of MuIFN a on MHC-I up-regulation 
on primary macrophages from Balb/c mice 
I 
Two 8-10 week male Balb/c mice were injected i.p. with 1.5 ml TG broth. 3 d 
later, the mice were killed and peritoneal exudate cells (PEC) were harvested with 
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cold DPBS in 15 ml centrifuge tube. The PECs were washed once with DPBS and 
once with RPMI-10 medium. They were then resuspended in cold RPMI-10 medium 
at 5x10^ cells/ml. 2 ml of the cell suspension was added to each well of a 6-well plate. 
3 h later the unattached cells were washed away using RPMI-10 medium. 2 d later, 
mock supernatant or 500 LU/ml of MuIFN al2, a l , a4 or mixed type I IFN were 
added. 48 h later, the cells were harvested with DPBS containing 0.2% EDTA by 
incubating at 37�C for 5 min and then p^etting up and down to detach the cells from 
the culture plate. The cells were then processed as the JCS cells in 2.2.12. 
2.2.14 Anti-viral activity by transfection of MuIFN a gene 
The assay was performed as described (Harle et oL’ 2002). Briefly, 2x10^ L929 
cells per well were seeded in a 6-well plate. When the cells were cultured to 60-80% 
confluent, the cells were transfected with 3 fig plasmid DNA of pEGFP-Nl, 
pEGFP-Nl_MuIFNal2 or pEGFP-Nl_MuIFNa4 using the DMRIE-C reagent as 
described in 2.2.4. 24 h after the addition of the 20% FCS medimn, the supematants 
were removed and the cells were challenged with vims at M01=0.2 as described in 
2.2.7. 16 to 20 h later, the cultures were observed under light microscopy and photos 
were taken. The protection was determined by the degree of cytopathic effect. 
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2.2.15 Sequencing of MuIFN al2 coding region from genomic DNA 
of L929 and JCS cell lines. 
Genomic DNA from L929 and JCS cell lines were prepared as in 2.2.1.1. PCR 
was performed on them with primer pairs MFl 107/1108 using thermoprime plus 
polymerase. The PCR products of size -600 bp were purified and extracted using the 
QIAEX II kit as in 2.2.1.2. Sequencing of the PCR products using primer MF1012, 
MF1013, MFl 107 or MFl 108 were done as described in 2.2.1.4. 
2.2.16 RNA extraction from L929 cell lines，with or without Influenza 
A virus infection or polyI:polyC induction 
L929 cells were seeded in 6-well plates until confluent. Then 200 |ig/ml 
polyI:polyC and 100 jag/ml Dextran were added. After 9 h of incubation, RNA was 
collected by the CsCl method. For the cells infected with Influenza A virus at 
M01=0.2, the RNA was also collected by the CsCl method 9 h after the re-supply of 
medium. The cells were lysed in 4M GT solution, with the help of syringe to break 
down the genomic DNA. The lysate was loaded onto 5.7M CsCl cushion and 
ultracentrifiiged at 160,000 g for 16 h. The supernatant was careftilly removed and the 
RNA was ehited with DEPC water. The RNA samples were further purified by the 
Trizol reagent as described in the manual. RNA samples were mixed 1:10 with Trizol 
reagent and made up to 1 ml. The sanq)les were incubated for 5 min at room 
tenq)erature. To each tube 0.2 ml of chloroform was added and the tube was shaken 
vigorously by hand for 15 s and incubated at room tenq)erature for 2 to 3 min. The 
samples were then centrifuged at 12,000 g for 15 min at 4®C to separate into 3 layers. 
The colorless upper aqueous phase was collected. RNA was precipitated by adding 
V i 
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0.5 ml of isopropyl alcohol. The samples were incubated at room tenq)erature for 10 
min and centrifliged at 12,000 g for 10 min at 4°C. The supernatant was removed, and 
the pellet was washed with 1 ml 75% ethanol prepared with DEPC water. The 
samples was mixed and centrifliged again for 30 min at 4°C at 1,4000 rpm. 
Supernatant was removed as much as possible, and the samples were air dried. The 
RNA was then dissolved in DEPC water and the amount was determined by 
measuring OD260. After that the samples were treated by RNase-free DNasel 
(Promega). Briefly, RNA samples were incubated with 1 |il of lOx reaction buffer 
(RQl RNase-Free Dnase, Promega) and 1 unit of RNas-free DNasel per |j,g of RNA 
in 10 |j,l reaction vohime, at 37�C for 30 min. The RNA samples were then 
immediately extracted with PCI and ethanol precipitated. The whole experiment was 
repeated once. 
2.2.17 RNA extraction from tissues of Balb/c mouse 
3 male 8-10 weeks Balb/c mouse were killed and the brain, bone marrow, heart, 
kidney, liver, hmg, spleen and thymus were collected. They were lysed in 4M GT 
solution* with the help of syringe to break down the genomic DNA. The lysates were 
proceeded as in 2.2.16 and were fiirther purified by Trizol reagent and treated by 
RNase-free DNasel as above. The whole experiment was repeated once. 
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2.2.18 Reverse Transcription 
RNA were diluted into 1 ng in 10 |il and added to 10 i^l reaction mixture which 
contains 2 \i\ DDT, 4 [i\ 5x 1 坟 strand buffer, 1 |xl dNTP (10 nM each), 1 i^l oligo dT, 1 
Rnasin and 1 |il ofMMLV-RT enzyme. The RT reactions were carried out at 37°C 
for 1 h and then boiled at 95°C for 5 min to separate the RNA from the cDNA. The 
RNA samples were diluted at the same concentration as the RT negative control. 
2.2.19 Polymerase Chain Reaction (PCR) 
For cloning purposes, the PCR were done using polymerase with proof-reading 
ability, e.g. Advantage 2, or For analysis purposes, they were performed using 
Thermoprime phis polymerase (AB gene). For a 50 reaction, 25 pmol of each 
primer was used, and 10 nM dNTP mix was added. The PCR profile for primer pair 
(MF1107/MF1108) was 94�C 30 s, then 35 cycles of 94°C for 20 s, 60�C for 20 s, 
72�C for 1 min. 
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Chapter 3 Results 
3.1 Overview 
The genes MuIFN a 12，al and a4 were successfully subcloned into the 
pEGFP-Nl vector. Recombinant murine interferon alpha subtypes were produced in 
COS-1 cells. The recombinant MuIFN al2, a l and a4 showed the characteristic IFN 
properties, i.e. anti-proliferative, immunomodulation (MHC-I up-regulation) and 
anti-viral activities. In addition, flow cytofluorometric analysis showed that MuIFN 
a l 2 and MuIFN a4 could induce apoptosis in JCS cells. However, no MuIFN a l2 
expression could be detected in the tissues of untreated Balb/c mice nor in L929 cells 
after infected with Influenza A vims or inducted by polyI:polyC. 
3.2 Subcloning of MuIFN al2，MuIFN a l and 
MuIFN a4 coding sequences into the pEGFP-Nl 
vector 
MuIFN a l2 coding region was PGR amplified from the genomic DNA of L929 
cells using primer pair (MF1012/MF1013) as described in 2.2.1.1. The fragment was 
successfully cloned into the EcoR V TA-cloning insertion site of pGEM-T vector. The 
recombinant plasmid was isolated and confirmed by DNA sequencing. The fragment 
was then subcloned into the pEGFP-Nl vector and designated 
pEGFP-Nl_MuIFNal2 as described in 2.2.1.5. MuIFN a l and MuIFN a4 coding 
region was PGR amplified from the genomic DNA of L929 cells as described in 
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2.2.1.6 and cloned into the pEGFP-Nl vector to generate the recombinant plasmids 
pEGFP-Nl一MuTFNal and pEGFP-Nl_MuIFNa4 respectively. 
3.3 The growth inhibitory effect of different MuIFN a 
subtypes on murine myeloid leukemia cell line JCS 
Recombinant MuIFN a 12，MuIFN a l and MuIFN a4 were expressed in COS-1 
cells as described in 2.2.4. The transfection of COS-1 cell line with empty pEGFP-Nl 
vector was referred as the mock transfection. The supernatant collected in this mock 
transfection was referred as the mock supernatant and was used to ensure that 
transfection of the empty vector will not produce factors that have properties similar 
to the recombinant MuIFN. 
JCS cells seeded in 96 well plate were treated with two fold dilutions of the 
rMuIFN as described in 2.2.9. 72 h later, MTT reagent was added and incubated for 3 
h at 37°C. The OD540 and ODew were measured. The % of growth inhibition effect of 
rMuIFN was calculated as (OD of treated sample / OD of untreated control) x 100%. 
The amount of rMuIFN which bring about 50% growth inhibition was referred as one 
laboratory unit. In fiirther measurement of rMuIFN, OD readings out of a previously 
established linear range were omitted. 
Fig. 3.1a to 3. If showed the effect of different MuIFN a subtypes on the growth 
of the murine myeloid leukemia cell line JCS. IC50 (50% growth inhibition) can be 
estimated from the plot of % growth inhibition vs amount of IFN added (in terms of 
|il). As shown in Fig. 3.1b, the mock supernatant could hardly inhibit the growth of 
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the JCS cells. In comparison, the rMxiIFN (Fig. 3.1c to 3.1e) as well as native, mixed 
type I IFN (Fig. 3.1f), could inhibit the growth up to about 80% of control. The 
inhibitory effects were dose-dependent. However, the curves tend to plateau at high 
concentrations. 
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Fig. 3.1 Effect of different MuIFN a subtypes on the growth of murine myeloid 
leukemia cell line JCS. 
3.1a showed the effect of different MuIFN a subtypes on the growth of murine 
myeloid leukemia cell line JCS. Briefly, JCS were cultured in 96 well plates with 2x 
dilution of MuIFN al2, a l or a4. 72 h later, 20 \x\ MTT reagent was added and the 
cells were incubated for further 3 h at 37�C, 5% CO2. The cells were then spun down. 
Medium was removed and lOOjul DMSO was added. OD at 540nm and 690mn was 
then measured. The OD of sample was calculated as OD540-OD690. The data were 
plotted as OD of samples / OD of cell only control x 100% (Y-axis) vs amount of 
MuIFN added in \x\ (X-axis). 1 Laboratory unit of IFN is defined as the amount that 
brings about 50% of growth inhibition. Rectangular hyperbola was fit onto the data 
points by Prism 4.0 software. 3.1c, d, e and f showed the effect of rMuIFN al2, 
a l , a4 or mixed type I IFN on the growth of JCS cells respectively. 3.1b showed the 
effect of the mock supernatant on the murine myeloid leukemia cell line JCS. As it 
could hardly give any growth inhibition, its laboratory unit could not be defined. 
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Fig. 3.1a Overlap of all results. 
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3.4 Quantitation of MuIFN a subtype samples 
To quantitize the MuIFN a subtype, our laboratory unit (LU) is defined as the 
amount of MuIFN a needed to bring about 50% growth inhibition on the murine 
myeloid leukemia JCS based on the MTT cell proliferation assay as described in 2.2.9. 
The values were calculated by the Prism 4.0 software. By using this system and 
definition, we found that usually our rMuIFN a preparations (as well as the mixed 
type I IFN preparations) have about 10,000 unit/ml. The IC50 for the rMuIFN al2, a l , 
a4 and mixed type I IFN were 0.102, 1.10，0.0934, 0.407 [i\ respectively. Thus 
represent 9710, 909, 10800, 2450 LU/ml respectively. For the mock supernatant, the 
definition of laboratory unit did not apply. Since the mock supernatant hardly have 
any effect on growth inhibition of the JCS cells, its laboratory unit could not be 
defined. Thus in latter experiments, mock supernatant with volumes comparable to 
the rMuIFN a l 2 preparation was used as control. 
3.5 Cell cycle analysis of MuIFN a treated JCS cells 
The MuIFN a treated JCS cells were stained with propidium iodide and subject 
to FACS analysis as described in 2.2.11. The % of cells with DNA content less than 
diploid (sub-Gi peak), which was assumed to undergo apoptosis, was calculated with 
the software Modfit. 
f 
Fig. 3.2 showed the cell cycle distribution of JCS cells without treatment or with 
mock supernatant, rMuIFN a l2 or rMuIFN a4. Fig. 3.2a and 3.2b showed the cell 
cycle distribution of untreated JCS cells and JCS cells treated with 200 \x\ mock 
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supernatant. It was noticed that at this amount, the mock supernatant had little or no 
effect on the JCS cells. In both cases, only very few cells were found to be within the 
sub-Gi region. Fig. 3.2c showed the cell cycle distribution of JCS cells treated with 
200 LU/ml of rMuIFN all. Debris and sub-Gi peak were detected. Fig. 3.2d showed 
the result for JCS cells treated with 200 LU/ml of rMuIFN a4. Same as in the case 
with rMuIFN al2, debris and sub-Gi peak were found. The % of cells within the 
sub-Gi region was found to be about <0.5%, <0.5%, ~10% and -10% for untreated, 




Fig. 3.2 Flow cytofluorometric analysis of MuIFN a treated JCS cells by 
propidium iodide staining. 
1x10^ JCS cells cultured in 10 ml RPMI-10 medium were treated with 200 |il mock 
supernatant, 200 LU/ml of rMuIFN a l2 or 200 LU/ml of rMuIFN a4 for 24 h and 
then fixed and stained with propidium iodide as described in 2.2.11. Untreated JCS 
cells fixed and stained in the same way were used as control. Fig. 3.2a showed the 
measurement of DNA content for untreated JCS cells. Fig. 3.2b showed the 
measurement of DNA content for 200 i^ il mock supernatant treated JCS cells. Note 
that only little cells were within the sub-Gi region. Fig. 3.2c showed the measurement 
of DNA content of JCS cells treated with 200 LU/ml rMuIFN al2. About 10% of the 
cells were within sub-Gi region, and were assumed to have undergone apoptosis. Fig. 
3.2d showed the measurement of DNA content of JCS cells treated with 200 LU/ml 
rMuIFN a4. Again, about 10% of the cells were within sub-Gi region. The % of cells 
undergone apoptosis were analysed by the software Modfit. 
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Fig. 3.2a Untreated JCS cells. 
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Fig. 3.2b JCS treated with 200 [i\ mock supernatant. 
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3.6 FACS analysis of the effect of different MuIFN a 
subtypes on MHC-I expression in JCS cell line. 
JCS cells were treated with different dosage (5，50 and 500 LU/ml) of 
recombinant MuIFN al2, a l , a4, mixed type I IFN or con^arable volume of mock 
supernatant for 36 h. The cells were then subjected to FACS staining as described in 
2.2.12. The antibody used in the staining process was FITC-conjugated anti-mouse 
MHC-I antibody. In the FACS chart, the X-axis denotes the log FLl signal while the 
Y-axis denotes the events (cell number counted). 
Fig. 3.3a showed the effect of 500 LU/ml of different recombinant MuIFN a 
subtypes on the up-regulation of MHC-I in JCS cells. With the addition of 500 LU/ml 
of rMuIFN a 12, rMuIFN a l , rMuIFN a4 or mixed type I IFN, the peak was shifted 
to the right, which mean more cells were of higher log FLl signal, i.e. MHC-I 
expression were up-regulated. In contrast, conq)arable volume of mock supernatant 
did not up regulate MHC-I expression in the JCS cells. 
Different amount of rMuIFN a 12, a l , a4 or mixed type I IFN (from 5 LU/ml, 
50 LU/ml to 500 LU/ml) were used to treat the JCS cells. The results were shown in 
Fig. 3.3b to Fig. 3.3e. The charts showed that the up-regulation of MHC-I expression 
in JCS cells by different MuIFN a subtypes were dose dependent. In contrast, none of 
the sanq)les treated with mock supematants have MHC-I expression up-regulated. 
(Fig. 3.3f). 
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Fig. 3.3 FACS charts showing the effect of different MuIFN a subtypes on the 
expression of MHC-I in JCS cell line. 
Fig. 3.3a FACS chart showed the effect of different MuIFN a subtypes on the 
expression of MHC-I in JCS cell line. Briefly, 1x10^ JCS cells were incubated with 
500 LU/ml of rMuIFN a for 36 h and then stained with FITC-conjugated anti-mouse 
MHC-I antibody as described in 2.2.12. X-axis denotes the log FLl signal while the 
Y-axis denotes the events (cell number counted). 500 LU/ml of rMuIFN al2， 
rMuIFN a l , rMuIFN a4 and native, mixed type I IFN could up-regulate the 
expression of MHC-I by different magnitudes. In contrast, comparable volume of 
mock supernatant did not show any effect. Fig 3.3b to 3.3f showed the effect of 
different dose of rMuIFN on the MHC-I expression in JCS cells. 
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Fig. 3.3a Effect of different MuIFN on MHC-I expression of JCS cells. 
m . , 
FLl LOG 104 个 
Shaded, unfilled black ( )，unfilled bright green ( )，unfilled blue ( 
一)，unfilled violet ( ) and unfilled turquoise ( ) histograms represent 
untreated JCS cells, JCS cells treated with 500 |il mock supernatant, 500 LU/ml of 
rMuIFN a 12’ rMuIFN a l , rMuIFN a4 or native mixed type I IFN respectively. In the 
figure the unfilled bright green and the unfilled turquoise histograms overlapped 
extensively. 
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Fig. 3.3b MHC-I expression of JCS cells treated with 5, 50 or 500 LU/ml of rMuIFN 
a l2 . 
iik 
10" 10' lb, 10' 10 ‘ 
FLl LOG 
10'个 
Shaded, unfilled blue ( ), unfilled bright green ( ) and unfilled black (一 
)histograms represent untreated JCS cells, JCS cells treated with 5, 50 or 500 
LU/ml of rMuIFN a l 2 respectively. 
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Fig. 3.3c MHC-I expression of JCS cells treated with 5, 50 or 500 LU/ml of rMuIFN 
a l . 
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Shaded, unfilled blue ( ), unfilled bright green ( ) and unfilled black (一 
)histograms represent untreated JCS cells, JCS cells treated with 5，50 or 500 
LU/ml of rMuIFN a l respectively. 
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Fig. 3.3d MHC-I expression of JCS cells treated with 5，50 or 500 LU/ml of rMuIFN 
cx4 
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Shaded, unfilled blue ( )’ unfilled bright green ( ) and unfilled black (— 
)histograms represent untreated JCS cells, JCS cells treated with 5，50 or 500 
LU/ml of rMuIFN a4 respectively. 
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Fig. 3.3e MHC-I expression of JCS cells treated with 5，50 or 500 LU/ml of native, 
mixed type I IFN. 
FLl LOG 
10'个 
Shaded, unfilled blue ( ), unfilled bright green ( ) and unfilled black (一 
)histograms represent untreated JCS cells, JCS cells treated with 5, 50 or 500 
LU/ml of native, mixed type I MuIFN respectively. 
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Fig. 3.3f MHC-I expression of JCS cells treated with 5 50 or 500 |il of mock 
supernatant, 
k ^ ^ ^ 
• ；,'o； ‘ ‘ Vo-FLl LOG 104个 
Shaded, unfilled blue ( )，unfil led bright green ( ) and unfilled black (一 
)histograms represent untreated JCS cells, JCS cells treated with 5, 50 or 500 |il 
of mock supernatant respectively. All the four histograms overlapped extensively in 
the figure. 
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3.7 FACS analysis of the effect of different MuIFN a 
subtypes on MHC-I expression in primary 
macrophages of Balb/c mice 
Primary macrophages were prepared from two 8-10 weeks Balb/c mice. The 
primary macrophages were treated with 500 LU/ml of rMuIFN al2, a l , a4 or mixed 
type I IFN and stained with FITC-conjugated anti-mouse MHC-I antibody before 
subjected to FACS analysis as described in 2.2.12. 
Fig. 3.4a to 3.4e showed the effect of mock supernatant, rMuIFN al2, a l , a4 or 
mixed type I IFN on MHC-I expression in primary macrophages prepared from 
Balb/c mice, respectively. MuIFN al2, a l , a4 and mixed type I EFN could 
up-regulate the MHC-I expression in primary macrophages. 
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Fig. 3.4 Effect of different MuIFN a subtypes on MHC-I expression of primary 
macrophages 
Fig. 3.4a to 3.4e showed the effect of different rMuIFN a subtypes on MHC-I 
expression of primary macrophages prepared from 8-10 weeks male untreated Balb/c 
mice. Macrophages were prepared from two 8-10 weeks male Balb/c mice as 
described in 2.2.13. 500 LU/ml of rMuIFN a 12, a l , a4, mixed type I EFN or 
comparable amount of mock supernatant were added to the primary macrophages and 
incubated for 48 h. The cells were then harvested, stained with FITC-conjugated 
anti-mouse MHC-I antibody and subjected to FACS analysis. The X-axis denotes the 
log FLl signal while the Y-axis denotes the events (cell number counted). Fig. 3.4a 
showed that 100 of mock supernatant have no effect on the expression of MHC-I 
on primary macrophages. Fig. 3.4b to e showed that rMuIFN al2, a l , a4，mixed type 
I IFN could up-regulate MHC-I expression in primary macrophages. 
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Fig. 3.4a Macrophages treated with 100 yii mock supernatant 
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Shaded and unfilled black histograms represent untreated macrophages and 
macrophages treated with 100 i^l mock supernatant respectively. 
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Fig. 3.4b Macrophages treated with 500 LU/ml of rMuIFN a l2 
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Fig. 3.4c Macrophages treated with 500 LU/ml of rMuIFN a l 
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Fig. 3.4d Macrophages treated with 500 LU/ml ofrMuIFN a4 
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Fig. 3.4e Macrophages treated with 500 LU/ml of native type I IFN. 
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Shaded and unfilled black histograms represent untreated macrophages and 
macrophages treated with 500 LU/ml of native type I IFN respectively. 
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3.8 Effect of MuIFN a subtype transgenes on L929 
cells challenged with Influenza A virus 
Mouse L929 cells were trasnfected with pEGFP-Nl, pEGFP-Nl_MuIFNal2 or 
pEGFP-N 1 _MuIFNa4 as described in 2.2.14. 24 h after transfection, the cells were 
challenged with Influenza A virus at M01=0.2. 
Cells transfected with pEGFP-Nl_MuIFNal2 or pEGFP-Nl_MuIFNa4 showed 
very little cytopathic effect upon Influenza A vims infection (Fig. 3.5b and c). Cells 
transfected with empty pEGFP-Nl vector were bursted by the virus and most of the 
cells showed signs of dying (Fig. 3.5a). Cell only control, as a negative result, was 
normal (Fig. 3.5d). 
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Fig. 3.5 Effect of MuIFN a subtype transgene on L929 cells infected with 
Influenza A virus 
Fig. 3.5a to 3.5c showed the effect of transfection of pEGFP-Nl, 
pEGFP-Nl_MuIFNal2 or pEGFP-Nl_MuIFNa4 on the L929 cells infected with 
Influenza A vims. 2x10^ L929 cells were seeded per well of a 6-well plate. When the 
cells were about 60-80% confluent, they were transfected with 3 jig of pEGFP-Nl, 
pEGFP-Nl_MuIFNal2 or pEGFP-Nl_MuIFNa4 DNA as described in 2.2.14. 24 h 
later, they were challenged with Influenza A virus at M01=0.2 as described in 2.2.7. 
About 16 h later, photographs of the cell culture were taken. Many cells showed signs 
of dying in the culture transfected with pEGFP-Nl (Fig. 3.5a). But for cells 
transfected with pEGFP-Nl_MuIFNal2 (Fig. 3.5b) or pEGFP-Nl_MuIFNa4 (Fig. 
3.5c), the cultures did not show significant levels of virus infection and appeared to be 
similar to uninfected control cells (Fig. 3.5d). 
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Fig. 3.5b L929 cells transfected with pEGFP-NI MuIFNa 12 and infected with 
M01=0.2 Influenza A virus. 
• 
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Fig. 3.5c L929 cells transfected with pEGFP-Nl一MuIFN a 4 and infected with 
M01=0.2 Influenza A virus. 
m 
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Fig. 3.5d L929 cells not transfected nor infected as cell only control. 
國 
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3.9 Sequencing of MuIFN a l l coding region from 
genomic DNA of L929 and JCS cell line 
MuIFN a l2 coding region was amplified from genomic DNA of L929 or JCS 
cell lines with PCR primer pair (MF1107/MF1108). The PCR products were then 
purified and sequenced with primers MF1107, MF1108, MF1012 and MF1013 as 
described in 2.2.1.4. The PCR products were confirmed to be MuIFN a l2 (data not 
shown), and thus it is likely that the primer pair (MF1107/MF1108) could be used in 
RT-PCR to detect MuIFN a l2 transcripts in L929 cells. Since JCS cell line was 
derived from Balb/c mice, we assumed that this primer pair could also be used to 
detect MuIFN a l2 transcripts in the tissues of untreated Balb/c mice by RT-PCR. 
3.10 MuIFN all expression in untreated, Influenza A 
virus infected or polyI:polyC induced L929 cells 
RNA san^les were prepared from untreated, Influenza A virus infected or 
polyI:polyC induced L929 cells as described in 2.2.16. RNA samples were then 
subjected to detect for the MuIFN a4 and MuIFN a l2 expression by RT-PCR using 
primer pairs specific for MuIFN a4 or MuIFN a l2 (primer pairs MF696/MF697, 
MF1107/MF1108 respectively) as described in 2.2.18 and 2.2.19. GAPDH, the house 
keeping gene, was used as a control to verify the quality of RNA samples by 
performing RT-PCR using GAPDH specific primers (MF214/MF215). 
As shown in Fig. 3.6a, the detection of GAPDH only in RT+ but not RT-
samples suggested that there was no genomic DNA contamination in the RNA 
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samples. Fig. 3.6b showed that MuIFN a4 RNA can be detected in L929 cells 
infected for 9 h or L929 cells induced with polylipolyC for 9 h. However, it was not 
detected in untreated L929 cells or the RT- samples. Fig. 3.6c showed that no 
MuIFN a l 2 RNA was detected in untreated, virus infected or polyLpolyC induced 
L929 cells. The amplification of a band using L929 genomic DNA as +ve control 
suggested that there was no problem in the PCR setup. 
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Fig. 3.6 Detection of GAPDH, MuIFN a4 and MuIFN al2 transcripts in 
untreated, Influenza A virus infected or polyI:polyC induced L929 cells 
Fig. 3.6a showed the results of PCR on RT+ and RT- templates using GAPDH primer 
pair (MF214/MF215). GAPDH was only detected in RT+ samples. This was used to 
test for genomic DNA contamination. Briefly, PCR were performed using 2 [i\ RT 
products (for RT+ reactions, containing first cDNA products generated from 0.1 jig 
RNA) or 0.1 |Lig RNA samples (for RT- reactions) for 35 cycles as described in 2.2.19. 
5 (for RT+ samples) or 50 |il (for RT- samples) PCR products were analyzed in 
1% agarose gel with 0.5 |ig/ml EtBr. Lane 1-3, PCR of RT+ samples; lane 4-6，PCR 
of corresponding RT- san^les; lane 7, +ve control using L929 genomic DNA as 
ten^late; lane 8，negative control using water instead of RT or DNA tenq)late. 
Fig. 3.6b showed the detection of MuIFN a4 RNA in L929 cells infected with 
Influenza A virus for 9 h or L929 cells induced with polyI:polyC for 9 h. The primer 
pair MF696/MF697 was used to detect MuEFN a4 transcripts by RT-PCR for 35 
cycles. RNA samples were prepared from untreated, flu infected for 9 h or 
polyI:polyC induced for 9 h L929 cells as described in 2.2.16. PCR amplification of 
the RT+，RT-, +ve and -ve control saiiq)les were same as in Fig 3.6a. MuIFN a4 
transcripts were detected in Influenza A vims infected or polyI:polyC induced L929 
cells but not in untreated L929 cells. 
Fig 3.6c showed the detection of MuIFN a l2 RNA in untreated, virus infected or 
polyLpolyC induced L929 cells. RNA samples were prepared from untreated, 
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Influenza A virus infected for 9 h or polylipolyC induced for 9 h L929 cells as 
described in 2.2.16. MuIFN al2 specific primer pair (MF1107/MF1108) was used to 
detect its transcripts by RT-PCR for 35 cycles as described in 2.2.1.19. PGR 
an^lification of the RT+, RT-, +ve and -ve control samples were same as in Fig 3.6a. 
MuIFN a l2 transcripts were not detected in untreated cells, Influenza A virus infected 
or polylrpolyC induced L929 cells. The PGR using L929 genomic DNA as template 
showed that there was no problem with the PCR setup. 
81 
Fig. 3.6a: peR amplification ofGAPDH on RT+ and RT- templates of untreated, flu 
infected or polyI:polyC induced L929 cells. 
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Fig. 3.6b: PCR air5)lification of MuIFN a4 on RT+ and RT- templates of untreated, 
flu infected or polylipolyC induced L929 cells. 
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Fig. 3.6c: peR amplification ofMuIFN a12 on RT+ and RT- templates of untreated, 
flu infected or polyI:polyC induced L929 cells. 
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3.11 Detection of MuIFN all transcripts in tissues of 
the 8-10 week untreated Balb/c mice 
RNA san^les were prepared from brain, bone marrow, heart, kidney, liver, lung, 
spleen and thymus of the 8-10 week male untreated Balb/c mice as described in 2.2.17. 
RNA samples were then subjected to detect for the MuIFN al2 transcripts by 
RT-PCR using a pair of MuIFN al2 specific primers (MF1107/MF1108) as described 
in 2.2.18 and 2.2.19. RT-PCR of GAPDH, the house keeping gene, was used as a 
control to verify the quality of RNA samples. 
As shown in Fig. 3.7a, the detection of GAPDH only in RT+ but not RT-
samples suggested that there was no genomic DNA contamination in the RNA 
samples. Fig. 3.7b showed that no MuIFN a l2 RNA was detected in RNA samples 
obtained from brain, bone marrow, heart, kidney, liver, lung, spleen and thymus. 
Genomic DNA from L929 cell line and MilliQ water were used as +ve and -ve 
teirqjlates for the PCR reaction. 
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Fig 3.7 Detection of MuIFN al2 RNA in different tissues of untreated Balb/c 
mice 
Fig. 3.7a RT-PCR of GAPDH in RT+ or RT- RNA samples was used to detect for 
genomic DNA contamination. Briefly, PCR were performed using 2 |il RT products 
(for RT+ reactions, containing the first cDNA generated from 0.1 iiig RNA) or 0.1 jig 
RNA samples (for RT- reactions). The reaction profile was as described in 2.2.1.19 
for 35 cycles using primer (MF214/MF215). 
Fig. 3.7b Detection of MuIFN a l2 transcripts in various tissues from untreated Balb/c 
mice by RT-PCR. No MuIFN a 12 RNA could be detected in RNA sauries obtained 
from brain, bone marrow, heart, kidney, liver, lung, spleen or thymus. RNA was 
extracted from the tissues of 3 male untreated 8-10 week Balb/c mice as described in 
2.2.17. RT was performed as in 2.2.18. PCR was done for 35 cycles with primer pair 
MF1107/MF1108. For RT+ reactions, the PCR templates were 2 \i\ RT products 
(containing the first cDNA generated from 0.1 |ag RNA); for RT- reactions, 0.1 |ig 
RNA sanples were used as teiiq)lates directly. The profile was as described in 
2.2.1.19. Genomic DNA and MilliQ water were used as +ve and -ve templates for the 
PCR reaction. 
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Fig. 3.7a: PCR anqjlification ofGAPDH on RT+ and RT- RNA samples taken from 
different tissues of untreated Balb/c mice. Lane 1,9: bone; lane 2,10: brain; lane 3,11: 
heart; lane 4,12: kidney; lane 5,13: liver; lane 6,14: hmg; lane 7,15: spleen; lane 8,16: 
thymus; lane 17: L929; lane 18: H2O as template. 
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Fig. 3.7b: PCR anq)lification of MuIFN a l2 on RT+ and RT- RNA samples of 
different tissues of Balb/c mice. Lane 1,9: bone; lane 2,10: brain; lane 3,11: heart; 
lane 4,12: kidney; lane 5,13: liver; lane 6,14: lung; lane 7,15: spleen; lane 8,16: 
thymus; lane 17: L929; lane 18: H2O as teiiq)late. 
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Chapter 4 Discussion and Conclusion 
Discussion 
4.1 Overview 
In this study, we have successfully cloned a recently discovered novel murine 
interferon alpha subtype — MuIFN a 12 from murine L929 cell line. The recombinant 
MuIFN a 12 was expressed in mammalian expression system and the recombinant 
protein was found to be biological active. Our study on gene regulation suggested that 
in L929 cells MuIFN a 12 is not highly up-regulated by Influenza A virus infection 
nor polyI:polyC induction. And no expression could be detected in normal adult 
tissues taken from Balb/c mice. Compare with reports recently published by other 
groups, our data and the other reports supplement each other and bring more 
understanding to the biological functions and gene regulation of this recently 
discovered novel murine interferon alpha subtype. 
4.2 rMuIFN al2 has anti-proliferative and apoptotic 
effects on JCS cell line 
Although (van Pesch et al., 2004) have also reported that MuIFN a l 2 could have 
anti-proliferative effect on murine B16 melanoma cell line, we here have, in addition 
to similar results using JCS cells, shown a dose-response curve and studied its effect 
on cell cycle distribution by propidium iodide staining. In the study of the 
anti-proliferative effect, we defined one laboratory unit of MuIFN a as the amount 
that bring about 50% growth inhibition (IC50) of the JCS cells (Nedemian et al, 1990). 
89 
A common method, MTT cell proliferation assay, was used to measure the reduction 
in cell proliferation (Loveland et al.’ 1992). The inhibition curves for the rMuIFN a 
or mixed type I EFN sauries fit well onto a typical rectangular hyperbola but not the 
mock supernatant. The anti-proliferative effect of rMuIFN al2 on JCS cells showed a 
dosage-dependent response. We have further studied the underlying mechanism by 
studying the cell cycle distribution of the treated cells, using propidium iodide 
staining. IFN a is believed to bring about anti-proliferative effect at least by cell cycle 
arrest and/or by induction of apoptosis, and the two pathways can be independent to 
each other (Sandoval et al” 2004). We took an similar approach (Yanai et al” 2002; 
Oritani et al.，2000) by using propidium iodide staining and flow cytometry to analyze 
the DNA content of the cells. Briefly, JCS cells were treated with rMuIFN a for 24 h 
and stained with PI before subjected to flow cytometry analysis. PI binds 
stoichiometrically to DNA and gives out fluorescent upon activation. The fluorescent 
intensity thus correlates to the DNA content of the cell. The FACS chart of untreated 
cells should be able to show the relative ratio of cell populations in Go, Gi, S and 
G2-M phases. If rMuIFN a l2 can induce apoptosis, an apoptotic peak (in the sub-Gi 
region) will be observed. The ratio of the Gi and G2-M peak can tell whether 
rMuIFN a l 2 can induce cell cycle arrest at Go/Gi stage. DNA fragmentation assay, 
which shows characteristic DNA ladder formed in apoptosis, may also be performed 
as described (Oritani et al” 2000). In our results, we found that rMuIFN a l2 and 
rMuIFN a4 could induce apoptosis up to about 10% while <0.5% apoptosis was 
found in untreated or mock supernatant treated JCS cells. Our results suggested that 
rMuIFN a l2 could induce apoptosis in JCS cells and this may be one of the 
mechanisms that count for the anti-proliferative effect of rMuIFN a 12. 
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4.3 Up-regulation of MHC-I expression in JCS cells 
and primary macrophages by rMuIFN al2，rMuIFN 
al，rMuIFN a4 and mixed type I IFN 
MuIFNa are important in the first state of immune response against pathogens, 
especially in eliciting innate immune response. Their effects on immunomodulation 
include up-regulation of MHC-I expression, activation of NK cells and many others. 
In vitro cell culture system provides an easy way to study these activities, although 
this in vitrv model may be deviated from the in vivo situation. The experimental setup 
we used was similar to Yanai (Yanai et al” 2002). In this study, we showed that 
rMuIFN al2, as well as other MuIFN a, could up-regulation the expression of 
MHC-I on murine JCS cell line in a dose dependent manner within the first 36 h of 
induction. Since all FACS results were come from the same set of experiment, the 
magnitude of induction could be compared between the samples. We have also 
repeated the experiment by using primary macrophage. The results shown in 3.7 
demonstrated that rMuIFN a l2 and other MuIFN a we used as control could 
up-regulate MHC-I in primary macrophages taken from normal Balb/c mice. This 
indicated that rMuIFN a l2 like, the other MuIFN a, has an immunological function 
in mouse. Whether rMuEFN a l2 can augment murine natural killer cell activity 
(Brunda et al., 1981) is worth to investigate. 
4.4 Transfection of MuIFN a l2 gene could induce 
anti-viral state in L929 cell line 
Traditionally, the anti-viral activities of MuIFN a was demonstrated by 
incubation of cell culture with the candidate protein, followed by subsequent vims 
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challenge. The protection was then evaluated by cytopathic or plaque assay. However, 
our attempt to follow this approach was not easy as MuIFN a can hardly protect Mx-
cells effectively from Influenza A vims challenge (Meyer et al.，1984). Our 
preliminary attempts showed that the data did not fit to a typical sigmoid curve with a 
maximum of 100% protection. And it used up large amount of rMuIFN a. Thus we 
chose to take the approach as described by Harle (Harle et al.，2002) that the L929 
cells were transfected with MuIFN a genes before vims challenge. After transferred 
with the MuIFN a genes the cells were likely to produce rMuIFN a continuously 
through out the course of virus challenge and thus maintain a high dose of rMuIFN 
a in the supernatant. In feet this approach was shown to be practical that the 
protection by MuIFN a transgene was very clear-cut when con^aring with mock 
transfection. Although one may argue that the anti-viral effect of this transgene may 
act by other mechanisms, the result showed by van Pesch (van Pesch et al, 2004) had 
eliminated this possibility. Their results and ours supplement each other to 
demonstrate that the MuIFN a l2 could induce anti-viral state just like other MuIFN a. 
However, in our study, since the differences in the protection by the transgenes were 
very small, and transfection efficiency was hard to measure, our method could not tell 
the relative potency of different MuIFN a subtypes. 
4.5 Gene regulation of MuIFN al2 in L929 cells 
infected with Influenza A virus or induced by 
polylrpolyC 
Virus infection or dsRNA e.g. polylipolyC were excellent inducers of IFN a. 
Several MuIFN a subtypes were highly up-regulated by these signals (Fung et al, 
2004). However, the mRNA sequences of different subtypes were indeed very similar. 
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It is very difficult to determine the expression of each individual subtype, van Pesch 
and his colleagues (van Pesch et al, 2003) addressed this problem by using consensus 
primer to an^lify all MuIFN a mRNAs. The amplified cDNAs were cloned and 
sequenced to measure the relative level of gene expression. However the 
anq)lification will favor the highly expressed subtype(s) but bias for the low level 
expressed subtype(s). Our laboratory had recently reported a simple RT-PCR method 
to detect individual subtypes using primers which were specific to a unique subtype 
(Fung et al, 2004). During this study, murine interferon alpha subtype 12, 13 and 14 
were not yet discovered. Thus this tool, at the present time, may give some arguable 
results as we have not shown that our primers will not amplify MuIFN a subtype 12, 
13 or 14 by cross-PCR. Nonetheless, MuIFN a subtype expression induced by 
polyI:polyC for 9 h on L929 cells were both reported by (Fung et al.，2004) and (van 
Pesch et al., 2003 and 2004). By coinparing the results, the method by (van Pesch et 
al., 2004) seems to be less capable to reflect the truth. Hardly et al, 2004 have 
developed a pair of PCR primer that should specifically PCR MuIFN all 
(MFl 107/1108) in genomic DNA of mouse strain C57BL/6. We have tested that this 
primer pair could amplify the MuIFN a l2 gene from genomic DNA of L929 and JCS 
cells. We assumed that this primer pair was also applicable to detect MuIFN a l2 
mRNA expressed in L929 cell lines and Balb/c mice. Together with the primers 
developed by our group (Fung et al., 2004) for other known MuIFN a subtypes, we 
had better tools to study the gene regulation of MuIFN a l2 and other subtypes. 
RNA samples from untreated, flu infected or polyI:polyC induced L929 cells 
were purified by ultracentrifiigation with CsCl cushion, and then treated with Trizol 
reagent and RNase-free DNasel to minimize the occurrence of genomic DNA. 
GAPDH primers were used to test for genomic DNA contamination. To ensure that 
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virus infection or polyI:polyC induction was success, the RT+ and RT- samples were 
amplified using MuIFN a4 specific primer to show the expression of MuIFN a4. To 
demonstrate that the negative results were not due to experimental feilure and the 
positive results were not due to genomic contamination or contamination of reagents, 
L929 genomic DNA or autoclaved MilliQ water were used as positive control and 
negative control ten^lates in the PCR experiments. However, we could not detect any 
MuIFN a l 2 mRNA in our samples by PCR. The result suggested that Influenza A 
vims infection and polyI:polyC induction did not induce the expression of MuIFN 
a 12. Different viruses could induce the expression of different MuIFN a subtypes 
(Fung et al, 2004). Whether MuIFN al2 could be induced by other vims or inducers 
need to be investigated. 
4.6 Gene expression of MuIFN al2 in different tissues 
of Balb/c mice 
Hardy and his colleagues had shown that MuIFN a l2 could be detected in 
murine embryo fibroblasts cDNA library (Hardy et al” 2004). This could imply that 
MuIFN a l 2 may be differentially expressed during embryo development. And 
endogenous IFN expressions were reported and suggested previously (Riego et al, 
1995). MUIFN a l 3 is indeed a unique MuIFN a subtype that is constitutively 
expressed in L929 cells in low-level and is not up-regulated by Mengo virus induction 
(van Pesch et al.，2003). van Pesch had also used their method to show that MuIFN 
a l 2 was expressed in brain tissue of 129/Sv mice. We therefore speculated that 
MuIFN a l 2 might be expressed in some tissues of normal Balb/c mice. However, 
MuIFN a l2 transcripts could not be detected in brain, bone marrow, heart, kidney, 
liver, hmg, spleen and thymus of normal Balb/c mice by RT-PCR. MuIFN all 
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expression could not be detected in the Balb/c mice brain tissue was somehow 
different from van Pesch's report (van Pesch et al； 2003) that MuIFN a l2 was 
expressed in the brain of 129/Sv strain mice. Whether the expression of MuIFN a l2 
is different among different mouse strains needs further investigation. It may be also 
interesting to study how MuIFN al2 expression is regulated when the mouse 
develops from embryo to adult, as it is suggested by Riego that the endogenous IFN 
may act as autocrine or paracrine during development (Riego et al, 1995). 
Conclusion 
Taking together the pervious studies and the DNA sequence of the mouse 
genome, the mouse interferon alpha family should contain at least 14 members (van 
Pesch et al.，2004). MuIFN al2, 13 and 14 may encode new fimctional interferon 
alpha subtypes. Here we have demonstrated that the MuIFN al2 gene is encoding a 
functional interferon alpha subtype. This new alpha subtype has anti-proliferative, 
anti-viral and immunomodulative functions. This MuIFN al2 does not express in 
Influenza A virus infected or polyI:polyC induced L929 cells. MuIFN a l2 is 
differentially expressed during embryo development and may act as an autocrine or 
paracrine factor. 
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